Balyasny Asset Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-231,442
| Closed | -$606K | – | 2401 |
|
|
2025
Q1 | $606K | Sell |
231,442
-460,837
| -67% | -$1.21M | ﹤0.01% | 1516 |
|
|
2024
Q4 | $2.85M | Buy |
+692,279
| New | +$2.85M | ﹤0.01% | 1010 |
|
|
2024
Q3 | – | Sell |
-65,989
| Closed | -$430K | – | 2302 |
|
|
2024
Q2 | $430K | Sell |
65,989
-933,650
| -93% | -$6.09M | ﹤0.01% | 1508 |
|
|
2024
Q1 | $8.3M | Buy |
+999,639
| New | +$8.3M | 0.01% | 736 |
|
|
2023
Q4 | – | Sell |
-51,971
| Closed | -$437K | – | 2213 |
|
|
2023
Q3 | $437K | Sell |
51,971
-265,998
| -84% | -$2.24M | ﹤0.01% | 1344 |
|
|
2023
Q2 | $3.99M | Buy |
+317,969
| New | +$3.99M | 0.01% | 837 |
|
|
2023
Q1 | – | Sell |
-203,168
| Closed | -$3.04M | – | 2573 |
|
|
2022
Q4 | $3.04M | Buy |
+203,168
| New | +$3.04M | 0.01% | 911 |
|